 |
|
Clinical Investigators— The Endangered Species Revisited
Edward D. Miller, MD
JAMA. 2001;286:845-846.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
The premise that clinical research needs to be strengthened was placed squarely on the medical agenda more than 2 decades ago. In his landmark paper "The Clinical Investigator as an Endangered Species," Wyngaarden1 described a number of problems that he believed jeopardized the future of clinical research. These included declining interest in biomedical research and decreases in the number of postdoctoral training awards granted to young clinicians. The solution he proposed, implementing a series of steps to encourage young physicians to pursue biomedical research careers, has in many respects been adopted. For example, the National Institutes of Health (NIH) has developed a number of new grant mechanisms, such as the K23 and K24 awards, designed to encourage clinical investigators to compete for peer-reviewed funding. This measure and numerous others, implemented by funding agencies and by individual academic health centers, have succeeded in the sense that today . . . [Full Text of this Article]
Author Affiliation: Dean and CEO, Johns Hopkins Medicine, Baltimore, Md.
RELATED ARTICLE
Status of Clinical Research in Academic Health Centers: Views From the Research Leadership
Eric G. Campbell, Joel S. Weissman, Ernest Moy, and David Blumenthal
JAMA. 2001;286(7):800-806.
ABSTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Maternal Cognitions about Distress and Anxiety in Young Latino Children with Disruptive Behaviors
Arcia et al.
Transcultural Psychiatry 2004;41:99-119.
ABSTRACT
NIH Peer Review of Grant Applications for Clinical Research
Kotchen et al.
JAMA 2004;291:836-843.
ABSTRACT
| FULL TEXT
Research Training in the Czech Republic
Balon and Hoschl
Acad. Psychiatry 2002;26:125-127.
FULL TEXT
|
